Antiviral compounds and uses thereof

US9637478B2 · kind B2 · utility

Assignee

• Abb Vie Inc. · US

Inventors

• David A. Betebenner · Lawrenceville, US
• John K. Pratt · Kenosha, US
• David A. DeGoey · Salem, US
• Pamela L. Donner · Mundelein, US
• Charles A. Flentge · Salem, US
• Douglas K. Hutchinson · Antioch, US
• Warren M. Kati · Gurnee, US
• Allan C. Krueger · Gurnee, US
• Kenton L. Longenecker · Grayslake, US
• Clarence J. Maring · Libertyville, US
• John T. Randolph · Libertyville, US
• Todd W. Rockway · Gurnee, US
• Michael D. Tufano · Chicago, US
• Rolf Wagner · Antioch, US
• Dachun Liu · Vernon Hills, US

Key dates

• Filing date: Apr 28, 2016
• Grant date: May 2, 2017
• Expiry date: Apr 28, 2036

Classification

• Technology area (CPC Y): Emerging Cross-Sectional Technologies
• CPC primary: Y02P20/55
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

This invention relates to: (a) compounds and salts thereof that, inter alia, inhibit HCV; (b) intermediates useful for the preparation of such compounds and salts; (c) compositions comprising such compounds and salts; (d) methods for preparing such intermediates, compounds, salts, and compositions; (e) methods of use of such compounds, salts, and compositions; and (f) kits comprising such compounds, salts, and compositions.